首页> 外文期刊>Placenta >An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses.
【24h】

An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses.

机译:对胎儿进行适当生长或生长受限的胎儿的胎盘中I型胰岛素样生长因子受体的免疫组织化学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Insulin-like growth factors (IGFs) and their receptors in the fetus are essential for growth and postnatal survival but the role of maternal IGFs is less well understood. Animal and in vitro evidence suggests that maternal IGF-I may have important effects on placental function. Recent work in humans suggests that although there is no relationship between maternal serum IGF-I and normal fetal growth, levels are low in pregnancies complicated by fetal growth restriction due to placental dysfunction. A prospective and observational study was undertaken of the distribution and concentration of placental type I IGF receptors (IGF-IR) in women with small for gestational age (n=26) or appropriately grown (n=14) fetuses. Women were scanned biweekly from 24 weeks to delivery and cases (birthweight <5th centile) were assigned to two groups: 'fetal growth restriction' (FGR; umbilical artery pulsatility index [UAPI] > +2 s.d.; n=16) and 'normal small for gestational age' (SGA; normal UAPI, growth velocity and amniotic fluid; n=10). Immunohistochemistry of the IGF-IR was performed on formol saline-fixed placental biopsies obtained at delivery. In control pregnancies IGF-IR were present in villous endothelium and stroma, trophoblast and decidua and their distribution and density were unchanged in both SGA and FGR pregnancies. We hypothesize that a therapeutic elevation of maternal IGF-I in FGR pregnancy might lead to enhanced placental function and so fetal growth. Our findings of normal localization and density of placental IGF-IR in FGR encourage us to extend our work to look at the effects of maternal IGF-I on the transport of glucose and amino acids.
机译:胎儿中的胰岛素样生长因子(IGFs)及其受体对于生长和产后生存至关重要,但对母体IGF的作用了解得很少。动物和体外证据表明,孕妇IGF-I可能对胎盘功能有重要影响。人体的最新研究表明,尽管孕妇血清IGF-I与正常胎儿生长之间没有关系,但是由于胎盘功能障碍,孕妇并发胎儿生长受限的情况下妊娠水平较低。进行了一项前瞻性和观察性研究,研究了胎龄小的(n = 26)或适当成长的(n = 14)胎儿的妇女胎盘I型IGF受体(IGF-IR)的分布和浓度。从24周到分娩每两周扫描一次妇女,并将病例(体重<5%)分为两组:“胎儿生长受限”(FGR;脐动脉搏动指数[UAPI]> +2 sd; n = 16)和“正常”小于胎龄”(SGA;正常的UAPI,生长速度和羊水; n = 10)。 IGF-1R的免疫组织化学是在分娩时用甲醛固定的胎盘活检组织上进​​行的。在对照妊娠中,绒毛状内皮和间质,滋养细胞和蜕膜中存在IGF-1R,它们在SGA和FGR妊娠中的分布和密度均未改变。我们假设FGR妊娠中孕妇IGF-I的治疗性升高可能导致胎盘功能增强,从而导致胎儿生长。我们在FGR中胎盘IGF-1R的正常定位和密度的发现鼓励我们扩展工作范围,以研究母体IGF-1对葡萄糖和氨基酸转运的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号